Kappac Pharma (Delisted) financials and balance sheet

BSE: 506938Pharmaceuticals & Biotechnology

Last traded ₹112.85 on 6 Jan 2015

Delisted on 23 Nov 2023.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Kappac Pharma annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹1.00 Cr, year to Mar 2019A loss in 10 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income−2.2
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax−2.2
  10. Tax0.0
  11. Net profit−2.2

What the company owns

  • Receivables₹20 Cr
  • Plant, investments and other assets₹14 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹34 Cr
  • Other liabilities₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.Kappac Pharma quarterly results

₹ croreMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 29 MayMar 2020Filed 24 JunMar 2021Filed 10 Jun
Revenue from operations–––––––1.000.000.00
–––––––1.050.020.03
Materials and goods bought–––––––1.000.000.00
Employee costs–––––––0.000.010.01
Other expenses–––––––0.050.000.01
Operating profit before depreciation–––––––−0.05−0.02−0.03
Operating margin–––––––−5.0%––
Materials, % of revenue–––––––100.0%––
Employee costs, % of revenue–––––––0.0%––
Other expenses, % of revenue–––––––5.0%––
Depreciation and amortisation–––––––0.000.000.00
Operating profit after depreciation–––––––−0.05−0.02−0.03
Other income–––––––0.000.00−2.17
Finance costs–––––––0.000.000.00
One-off items–––––––0.000.000.00
Profit before tax−0.06−0.08−0.08−0.08−0.02−0.04−0.01−0.05−0.02−2.20
Tax–––––––0.000.000.00
Net profit−0.06−0.08−0.08−0.08−0.02−0.04−0.01−0.05−0.02−2.20
Net margin–––––––−5.0%––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Earlier years, Mar 2008 to Mar 2011
₹ croreMar 2008Mar 2009Mar 2010Mar 2011
Revenue from operations−0.191.98––
Depreciation and amortisation0.07–––
Other income−0.19–––
Profit before tax−0.28–−0.01−0.05
Net profit−0.28–−0.01−0.05
Net margin149.5%–––
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 29 MayMar 2020Filed 24 JunMar 2021Filed 10 Jun
37.936.334.1
Share capital30.330.330.3
Reserves7.66.03.8
Borrowings5.40.00.0
5.50.10.1
Liabilities due after a year0.00.00.0
Total assets43.436.434.2
38.716.714.0
4.719.620.1
Net debt5.40.00.0
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 10 Jun
−2.73
−0.53
Receivables−0.54
Other working capital0.01
Capital spending0.00
Free cash flow−2.73
Cash from investing2.73
Cash from financing0.00
Dividends paid0.00
Shares bought back0.00
Shares issued0.00
Net change in cash0.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 29 MayMar 2020Filed 24 JunMar 2021Filed 10 Jun
Earnings per share−₹0.01–−₹0.02−₹0.01−₹0.73
Diluted earnings per share−₹0.01–−₹0.02−₹0.01−₹0.73
Book value per share––––₹11.27

Ratios

Standalone, years to March.

RatioMar 2019Filed 29 MayMar 2020Filed 24 JunMar 2021Filed 10 Jun
Revenue growth–−100.0%–
Return on equity−0.1%––
Return on capital employed−0.1%0.0%−0.1%
Debt to equity0.140.000.00
Receivable days0––
Inventory days0––
Payable days0––
Cash conversion cycle, days0––
Working capital days1,697––
Asset turnover0.020.000.00
Assets per rupee of net worth1.141.071.00
No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−6.2%
Measure3 years
Return on capital employed, average−0.1%
Asset turnover, average0.01
Debt to equity, average0.05

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations−2.73
Cash from investing2.73
Cash from financing0.00
Capital spending0.00
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets−6.23
A threshold marked as ours has no published figure; it is the line we read the check against.